Nykode Therapeutics AS (FRA:5VB)
0.2258
+0.0269 (13.52%)
Jan 27, 2026, 12:39 PM EST
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of €90.84 million as of January 30, 2026. Its market cap has increased by 21.94% in one year.
Market Cap
90.84M
Enterprise Value
37.41M
Revenue
6.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.23
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 549.42M to 90.84M, a decrease of -83.47%. That is a compound annual growth rate of -25.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 90.84M | 36.17% |
| Dec 30, 2025 | 66.71M | -20.85% |
| Dec 30, 2024 | 84.29M | -86.48% |
| Dec 29, 2023 | 623.47M | -20.78% |
| Dec 30, 2022 | 787.04M | -66.41% |
| Dec 30, 2021 | 2.34B | 15.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ParTec AG | 122.80M |
| CeoTronics AG | 114.91M |
| Samara Asset Group | 108.28M |
| Netfonds AG | 104.52M |
| MPH Health Care AG | 98.47M |
| SMG Hospitality SE | 86.25M |
| Meta Wolf AG | 81.22M |
| Path2 Hydrogen AG | 78.06M |